Your Advocates Ltd’s Aurinia Pharmaceuticals AUPH Stock Holding History

Your Advocates Ltd’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.96K	Hold	200	–	–	﹤0.01%	166
2025 Q4	$3.19K	Hold	200	–	–	﹤0.01%	169
2025 Q3	$2.21K	Hold	200	–	–	﹤0.01%	166
2025 Q2	$1.69K	Hold	200	–	–	﹤0.01%	162
2025 Q1	$1.61K	Hold	200	–	–	﹤0.01%	167
2024 Q4	$1.8K	Hold	200	–	–	﹤0.01%	166
2024 Q3	$1.47K	Hold	200	–	–	﹤0.01%	184
2024 Q2	$1.14K	Hold	200	–	–	﹤0.01%	195
2024 Q1	$1K	Hold	200	–	–	﹤0.01%	192
2023 Q4	$1.8K	Hold	200	–	–	﹤0.01%	176
2023 Q3	$1.55K	Hold	200	–	–	﹤0.01%	216
2023 Q2	$1.94K	Hold	200	–	–	﹤0.01%	213
2023 Q1	$2.19K	Hold	200	–	–	﹤0.01%	171
2022 Q4	$864	Hold	200	–	–	﹤0.01%	186
2022 Q3	$2K	Hold	200	–	–	﹤0.01%	143
2022 Q2	$2K	Sell	200 -1,500	-88%	-$16.8K	﹤0.01%	151
2022 Q1	$21K	Buy	1,700 +1,550	+1,033%	+$24K	0.01%	73
2021 Q4	$3K	Sell	150 -100	-40%	-$2.37K	﹤0.01%	140
2021 Q3	$6K	Buy	+250	New	+$3.97K	﹤0.01%	110

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Your Advocates Ltd's AUPH Position: Q1 2026 in Review

Your Advocates Ltd held its Aurinia Pharmaceuticals (AUPH) position steady in Q1 2026 at 200 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #166.

Your Advocates Ltd first reported a position in AUPH in Q3 2021 and has held it in 19 quarters since. The position peaked at $21K in Q1 2022. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

Your Advocates Ltd held 200 shares of Aurinia Pharmaceuticals worth $2.96K as of Q1 2026.
Your Advocates Ltd left its Aurinia Pharmaceuticals share count unchanged in Q1 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Your Advocates Ltd's portfolio in Q1 2026, its #166 holding.
Your Advocates Ltd first reported a position in Aurinia Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
Your Advocates Ltd's Aurinia Pharmaceuticals position peaked at $21K in Q1 2022.
259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Your Advocates Ltd's 13F filing for Q1 2026, filed 30 Apr 2026.